Key Financial Data Of Group

Fuji Pharma Co.,Ltd. - Filing #7726755

Concept As at
2018-03-31
2018-01-01 to
2018-03-31
2017-10-01 to
2018-03-31
2016-10-01 to
2017-09-30
As at
2017-09-30
2017-01-01 to
2017-03-31
As at
2017-03-31
2016-10-01 to
2017-03-31
Key financial data of group
Business results of group
Net sales
17,961,000,000 JPY
35,387,000,000 JPY
17,324,000,000 JPY
Ordinary profit (loss)
2,360,000,000 JPY
4,628,000,000 JPY
2,535,000,000 JPY
Profit (loss) attributable to owners of parent
1,743,000,000 JPY
3,301,000,000 JPY
1,789,000,000 JPY
Comprehensive income
1,730,000,000 JPY
4,067,000,000 JPY
2,376,000,000 JPY
Net assets
33,929,000,000 JPY
32,601,000,000 JPY
31,254,000,000 JPY
Total assets
49,848,000,000 JPY
49,551,000,000 JPY
47,523,000,000 JPY
Basic earnings (loss) per share
29.54
116.49
220.63
47.56
119.60
Diluted earnings per share
Equity-to-asset ratio
0.681 xbrli:pure
0.658 xbrli:pure
0.658 xbrli:pure
Net cash provided by (used in) operating activities
1,702,000,000 JPY
3,238,000,000 JPY
1,451,000,000 JPY
Net cash provided by (used in) investing activities
-233,000,000 JPY
-1,534,000,000 JPY
-780,000,000 JPY
Net cash provided by (used in) financing activities
-1,332,000,000 JPY
-3,042,000,000 JPY
-2,003,000,000 JPY
Cash and cash equivalents
5,624,000,000 JPY
5,503,000,000 JPY
5,497,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.